- Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations
-
Sheu WH, Chan SP, Matawaran , Deerochanawong C, Mithal A, Chan J, Suastika K, Khoo CM, Nguyen HM, Linong J, Luk A, Yoon KH
- KMID: 2470952
- Diabetes Metab J.
- 2020 Feb;44(1):11-32.
- doi: 10.4093/dmj.2019.0208
The prevalence of obesity in Asia is of epidemic proportions, with an estimated 1 billion overweight/obese individuals in the region. The majority of patients with type 2 diabetes mellitus (T2DM)... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
-
Ng CH, Chan KE, Chin YH, Zeng RW, Tsai PC, Lim WH, Tan DJH, Khoo CM, Goh LH, Ling ZJ, Kulkarni A, Mak LYL, Huang DQ, Chan M, Chew NW, Siddiqui MS, Sanyal AJ, Muthiah M
- KMID: 2531379
- Clin Mol Hepatol.
- 2022 Jul;28(3):565-574.
- doi: 10.3350/cmh.2022.0096
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) is closely associated with diabetes. The cumulative impact of both diseases synergistically increases risk of adverse events. However, present population analysis is predominantly conducted... -
- CITED
-
- Close
- SHARE
-
- Close
